However, a previous study reported that IL21-AS1 expression was downregulated in SLE CD4+ T cells and negatively correlated with SLEDAI, which may influence disease activity by participating in IL-2-mediated follicular regulatory T-cell activation in SLE (93). This evidence concerns the gene IL2 and systemic lupus erythematosus.